Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))

Rita Pavasini; Paolo G. Camici; Filippo Crea; Nicolas Danchin; Kim Fox; Athanasios J. Manolis; Mario Marzilli; Giuseppe M.C. Rosano; José L. Lopez-Sendon; Fausto Pinto; Cristina Balla; Roberto Ferrari

doi:10.1016/j.ijcard.2020.06.028

Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))

Rita Pavasini, Paolo G. Camici, Filippo Crea, Nicolas Danchin, Kim Fox, Athanasios J. Manolis, Mario Marzilli, Giuseppe M.C. Rosano, José L. Lopez-Sendon, Fausto Pinto, Cristina Balla, Roberto Ferrari

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	23-23
Numero di pagine	1
Rivista	International Journal of Cardiology
Volume	321
DOI	https://doi.org/10.1016/j.ijcard.2020.06.028
Stato di pubblicazione	Pubblicato - 2020

Keywords

Beta-blockers
Ivabradine

Accesso al documento

10.1016/j.ijcard.2020.06.028

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint

Entra nei temi di ricerca di 'Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))'. Insieme formano una fingerprint unica.

Cita questo

Pavasini, R., Camici, P. G., Crea, F., Danchin, N., Fox, K., Manolis, A. J., Marzilli, M., Rosano, G. M. C., Lopez-Sendon, J. L., Pinto, F., Balla, C., & Ferrari, R. (2020). Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008)). International Journal of Cardiology, 321, 23-23. https://doi.org/10.1016/j.ijcard.2020.06.028

@article{1aee48d3708a42a397db2347677c2983,

title = "Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))",

abstract = "N/A",

keywords = "Beta-blockers, Ivabradine, Beta-blockers, Ivabradine",

author = "Rita Pavasini and Camici, {Paolo G.} and Filippo Crea and Nicolas Danchin and Kim Fox and Manolis, {Athanasios J.} and Mario Marzilli and Rosano, {Giuseppe M.C.} and Lopez-Sendon, {Jos{\'e} L.} and Fausto Pinto and Cristina Balla and Roberto Ferrari",

year = "2020",

doi = "10.1016/j.ijcard.2020.06.028",

language = "English",

volume = "321",

pages = "23--23",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Science Ireland Limited:PO Box 85, Limerick Ireland:011 353 61 709600, 011 353 61 61944, EMAIL: [email protected], INTERNET: http://www.elsevier.com, Fax: 011 353 61 709114",

}

Pavasini, R, Camici, PG, Crea, F, Danchin, N, Fox, K, Manolis, AJ, Marzilli, M, Rosano, GMC, Lopez-Sendon, JL, Pinto, F, Balla, C & Ferrari, R 2020, 'Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))', International Journal of Cardiology, vol. 321, pagg. 23-23. https://doi.org/10.1016/j.ijcard.2020.06.028

Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008)). / Pavasini, Rita; Camici, Paolo G.; Crea, Filippo et al.
In: International Journal of Cardiology, Vol. 321, 2020, pag. 23-23.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008))

AU - Pavasini, Rita

AU - Camici, Paolo G.

AU - Crea, Filippo

AU - Danchin, Nicolas

AU - Fox, Kim

AU - Manolis, Athanasios J.

AU - Marzilli, Mario

AU - Rosano, Giuseppe M.C.

AU - Lopez-Sendon, José L.

AU - Pinto, Fausto

AU - Balla, Cristina

AU - Ferrari, Roberto

PY - 2020

Y1 - 2020

N2 - N/A

AB - N/A

KW - Beta-blockers

KW - Ivabradine

KW - Beta-blockers

KW - Ivabradine

UR - http://hdl.handle.net/10807/166625

U2 - 10.1016/j.ijcard.2020.06.028

DO - 10.1016/j.ijcard.2020.06.028

M3 - Article

SN - 0167-5273

VL - 321

SP - 23

EP - 23

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -

Pavasini R, Camici PG, Crea F, Danchin N, Fox K, Manolis AJ et al. Corrigendum to “Anti-anginal drugs: Systematic review and clinical implications” [Int. J. Cardiol. 283 (2019) 55–63] (International Journal of Cardiology (2019) 283 (55–63), (S0167527318360947), (10.1016/j.ijcard.2018.12.008)). International Journal of Cardiology. 2020;321:23-23. doi: 10.1016/j.ijcard.2020.06.028